Dyadic International, Inc. (DYAI): Price and Financial Metrics

Dyadic International, Inc. (DYAI): $1.06

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

F

Add DYAI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#294 of 341

in industry

DYAI Price/Volume Stats

Current price $1.06 52-week high $2.67
Prev. close $1.06 52-week low $0.93
Day low $1.04 Volume 5,000
Day high $1.09 Avg. volume 48,783
50-day MA $1.17 Dividend yield N/A
200-day MA $1.46 Market Cap 31.25M

DYAI Stock Price Chart Interactive Chart >


Dyadic International, Inc. (DYAI) Company Bio


Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd., as well as with the Israel Institute for Biological Research; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; research collaboration with Sanofi-Aventis Deutschland GmbH; research and commercialization collaboration with Serum Institute of India Pvt.; and nonexclusive research collaboration with WuXi Biologics. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.


DYAI Latest News Stream


Event/Time News Detail
Loading, please wait...

DYAI Latest Social Stream


Loading social stream, please wait...

View Full DYAI Social Stream

DYAI Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!